Consensus panel's assessment and recommendations on the use of 3 botulinum toxin type A products in facial aesthetics

In this summary article, the authors discuss the characteristics of abobotulinumtoxinA, incobotulinumtoxinA, and onabotulinumtoxinA. With 3 neuromodulators available in the US market, comparisons between and among products will invariably be made, so arguments for the most effective facial aesthetic...

Full description

Saved in:
Bibliographic Details
Published in:Aesthetic surgery journal 2013-03, Vol.33 (1 Suppl), p.35S-40S
Main Authors: Lorenc, Z Paul, Kenkel, Jeffrey M, Fagien, Steven, Hirmand, Haideh, Nestor, Mark S, Sclafani, Anthony P, Sykes, Jonathan M, Waldorf, Heidi A
Format: Article
Language:English
Subjects:
Botulinum Toxins, Type A - therapeutic use
Face
Humans
Rejuvenation
Skin Aging
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:In this summary article, the authors discuss the characteristics of abobotulinumtoxinA, incobotulinumtoxinA, and onabotulinumtoxinA. With 3 neuromodulators available in the US market, comparisons between and among products will invariably be made, so arguments for the most effective facial aesthetic uses of each neuromodulator are presented. Topics addressed in this article include patient expectations, toxin reconstitution and preparation, patient positioning, differences among products, the role of complexing proteins, and dosing and injection strategies. Recommendations are also provided by treatment area.
ISSN:1090-820X
1527-330X
DOI:10.1177/1090820X13480479